Silvija Šafranko, Drago Šubarić, Igor Jerković, & Stela Jokić. (2023). Citrus By-Products as a Valuable Source of Biologically Active Compounds with Promising Pharmaceutical, Biological and Biomedical Potential. MDPI AG.
Chicago Style (17th ed.) CitationSilvija Šafranko, Drago Šubarić, Igor Jerković, and Stela Jokić. Citrus By-Products as a Valuable Source of Biologically Active Compounds with Promising Pharmaceutical, Biological and Biomedical Potential. MDPI AG, 2023.
MLA (9th ed.) CitationSilvija Šafranko, et al. Citrus By-Products as a Valuable Source of Biologically Active Compounds with Promising Pharmaceutical, Biological and Biomedical Potential. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.